Multiple institutional logics analysis and policy suggestions on the use of national medical insurance negotiation drugs / 中国药房
China Pharmacy
; (12): 1683-1689, 2024.
Article
in Zh
| WPRIM
| ID: wpr-1039344
Responsible library:
WPRO
ABSTRACT
OBJECTIVE To clarify the institutional logics of the dilemma of the use of national medical insurance negotiation drugs(referred to as “national negotiation drugs”), and promote the implementation and use of these drugs in medical institutions. METHODS Based on the complex institutional environment in which medical institutions were situated, the theory of multiple institutional logics was used to construct an analytical framework for the behavioral choices of medical institutions, and reveal the mechanism of the difficulty in the use of national negotiation drugs by clarifying the interaction and conflict of multiple logics in this process, so as to put forward some measures. RESULTS & CONCLUSIONS There were contradictions and coupling among the state logic, market logic, social logic and professional logic in the use of national negotiation drugs. In the game of multiple logics, the market logic and professional logic tended to be risk-averse, the failed “pressure-type system” of state logic, and the social logic was weakened, which caused the lack of action in the use of national negotiation drugs with the goal of completing performance evaluations in the current medical institutions. Thus, it is suggested to unbundle the invisible policy restrictions on the use of national negotiation drugs, form the pressure and motivation of medical institutions by incentive and constraint mechanisms, respond to the clinical demand by establishing a green procurement channel, and construct the supervision mechanism on the use of national negotiation drugs by social force, etc., so as to enhance the effect of the national negotiation drugs.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
China Pharmacy
Year:
2024
Type:
Article